Skip to main content
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.190
-0.050 (-2.23%)
At close: Apr 28, 2026, 4:00 PM EDT
2.174
-0.016 (-0.75%)
After-hours: Apr 28, 2026, 7:44 PM EDT

Daré Bioscience Revenue

In the year 2025, Daré Bioscience had annual revenue of $1.03M with 10,429.36% growth. Daré Bioscience had revenue of $1.02M in the quarter ending December 31, 2025, a decrease of -1,708.36%.

Revenue (ttm)
$1.03M
Revenue Growth
+10,429.36%
P/S Ratio
30.95
Revenue / Employee
$42,925
Employees
24
Market Cap
31.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.03M1.02M10,429.36%
Dec 31, 20249.78K-2.80M-99.65%
Dec 31, 20232.81M-7.19M-71.92%
Dec 31, 202210.00M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evaxion 7.53M
CervoMed 4.01M
Dyadic International 3.09M
Pluri 1.34M
IGC Pharma 1.11M
Outlook Therapeutics 205.70K
Senti Biosciences Holdings 22.00K
Revenue Rankings

DARE News

More News